# Sargramostim for Myeloid Dendritic Cell Deficiency

> **NCT01871467** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 2 (actual)

## Conditions studied

- Dendritic Cell Deficiency

## Interventions

- **DRUG:** Sargramostim

## Key facts

- **NCT ID:** NCT01871467
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01871467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01871467, "Sargramostim for Myeloid Dendritic Cell Deficiency". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01871467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*